AstraZeneca Pharma India Limited

ASTRAZEN

Quarterly results

standalone

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 2026683

    Quarter₹ croreYoY
    Jun 2024388+31.2%
    Sept 2024408+31.2%
    Dec 2024440+44.0%
    Mar 2025480+25.4%
    Jun 2025526+35.8%
    Sept 2025559+37.0%
    Dec 2025612+38.9%
    Mar 2026579+20.4%
    Jun 2026683+29.7%
  • ₹ crore

    Jun 20269

    Quarter₹ crore
    Jun 20248
    Sept 20248
    Dec 20248
    Mar 202516
    Jun 202511
    Sept 20256
    Dec 20255
    Mar 20266
    Jun 20269
  • ₹ crore

    Jun 2026692

    Quarter₹ crore
    Jun 2024396
    Sept 2024416
    Dec 2024448
    Mar 2025497
    Jun 2025538
    Sept 2025565
    Dec 2025617
    Mar 2026585
    Jun 2026692
  • Cost structure
  • ₹ crore

    Jun 202679

    Quarter₹ crore
    Jun 202461
    Sept 202468
    Dec 202462
    Mar 202566
    Jun 202564
    Sept 202560
    Dec 202594
    Mar 202646
    Jun 202679
  • ₹ crore

    Jun 2026641

    Quarter₹ crore
    Jun 2024353
    Sept 2024365
    Dec 2024373
    Mar 2025412
    Jun 2025462
    Sept 2025487
    Dec 2025572
    Mar 2026525
    Jun 2026641
  • Exceptional items and tax
  • ₹ crore

    Jun 202651

    Quarter₹ crore
    Jun 2024-15
    Sept 202451
    Dec 202442
    Mar 202578
    Jun 202575
    Sept 202573
    Dec 202547
    Mar 202658
    Jun 202651
  • ₹ crore

    Jun 202613

    Quarter₹ crore
    Jun 2024-3
    Sept 202413
    Dec 202411
    Mar 202520
    Jun 202519
    Sept 202519
    Dec 202514
    Mar 202613
    Jun 202613
  • Profit
  • ₹ crore

    Jun 202638

    Quarter₹ croreYoY
    Jun 2024-12-121.9%
    Sept 202438-26.6%
    Dec 202431+95.2%
    Mar 202558+47.6%
    Jun 202556+573.6%*
    Sept 202554+41.1%
    Dec 202533+5.6%
    Mar 202645-23.0%
    Jun 202638-32.1%
  • Per share
  • ₹ per share

    Jun 202615.17

    Quarter₹ per share
    Jun 2024-4.72
    Sept 202415.37
    Dec 202412.34
    Mar 202523.30
    Jun 202522.33
    Sept 202521.69
    Dec 202513.04
    Mar 202617.95
    Jun 202615.17
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
388408440480526559612579683
Revenue YoY+31.2%+31.2%+44.0%+25.4%+35.8%+37.0%+38.9%+20.4%+29.7%
88816116569
396416448497538565617585692
Cost structure
616862666460944679
353365373412462487572525641
Exceptional items and tax
-155142787573475851
-31311201919141313
Profit
-123831585654334538
Net profit YoY-121.9%-26.6%+95.2%+47.6%+573.6%*+41.1%+5.6%-23.0%-32.1%
Per share
-4.7215.3712.3423.3022.3321.6913.0417.9515.17

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.